Abstract:IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis, whose prognosis is highly variable. Interstitial fibrosis is a strong independent prognosis factor. Among microRNA involved in renal fibrogenesis, only few have been investigated in IgAN. In the context of IgAN, we aimed to analyze the role of miR-21-5p, miR-214-3p and miR-199a-5p, three established “fibromiRs” involved in renal fibrosis. Fifty-six IgAN biopsy specimens were retrospectively scored according to Oxford classification. Renal… Show more
“…After measuring renal expression of miR-21-5p, miR-214-3p, and miR-199a-5p levels, Hennino et al confirmed that miR-21-5p acted as a “fibromiRs”, participated in the course of IgAN and closely linked with renal survival [25]. Furthermore, several publications suggested that circulating miRNAs levels might also represent a novel, predictive and reliable blood marker of kidney fibrosis [32-34].…”
Section: Discussionmentioning
confidence: 99%
“…Allow for previous reports of heightened renal MMP-7 expression in renal fibrosis and the significance of kidney fibrosis implicated in the pathogenesis of IgAN [25, 26], we hypothesized that the intrarenal fibrosis signature could be detected noninvasively by quantification of MMP-7 level in circulation and, it might serve as a noninvasive prognostic biomarker in IgAN. Since MMP-7 expression is little investigated in IgAN by now, in this study, we examined the association of serum MMP-7 level and histopathological change, as well as the renal progression of IgAN in a cohort of biopsy proven patients.…”
Background/Aims: In view of the latest findings that matrix metalloproteinase-7 (MMP-7) acted as a vital marker and pathogenic mediator of renal fibrosis in a murine model, we hypothesized that serum MMP-7 level might serve as a noninvasive prognostic biomarker in IgA nephropathy (IgAN) patients. Methods: We conducted a retrospective follow-up study of 244 IgAN patients for a median of 81.9 months. Serum MMP-7 was detected at the time of diagnosis, and renal progression was assessed by Cox proportional hazards method. Results: Compared with healthy populations, the serum levels of MMP-7 were significantly elevated in IgAN patients. Besides, serum MMP-7 levels were well correlated with renal scarring lesions characterized by glomerular sclerosis and interstitial fibrosis. Follow-up analyses revealed that increased serum MMP-7 levels were linked with a greater risk of poor renal outcome with a hazard ratio of 1.898 per doubling MMP-7 concentration. By contrast with the first quartile, the risk of deterioration in renal function elevated such that the hazard ratio for the second quartile was 1.805, 3.383 for the third, and 5.173 for the fourth quartile of the MMP-7 level. Conclusions: This study showed that the higher serum MMP-7 levels were independently associated with renal fibrosis and poor prognosis in IgAN.
“…After measuring renal expression of miR-21-5p, miR-214-3p, and miR-199a-5p levels, Hennino et al confirmed that miR-21-5p acted as a “fibromiRs”, participated in the course of IgAN and closely linked with renal survival [25]. Furthermore, several publications suggested that circulating miRNAs levels might also represent a novel, predictive and reliable blood marker of kidney fibrosis [32-34].…”
Section: Discussionmentioning
confidence: 99%
“…Allow for previous reports of heightened renal MMP-7 expression in renal fibrosis and the significance of kidney fibrosis implicated in the pathogenesis of IgAN [25, 26], we hypothesized that the intrarenal fibrosis signature could be detected noninvasively by quantification of MMP-7 level in circulation and, it might serve as a noninvasive prognostic biomarker in IgAN. Since MMP-7 expression is little investigated in IgAN by now, in this study, we examined the association of serum MMP-7 level and histopathological change, as well as the renal progression of IgAN in a cohort of biopsy proven patients.…”
Background/Aims: In view of the latest findings that matrix metalloproteinase-7 (MMP-7) acted as a vital marker and pathogenic mediator of renal fibrosis in a murine model, we hypothesized that serum MMP-7 level might serve as a noninvasive prognostic biomarker in IgA nephropathy (IgAN) patients. Methods: We conducted a retrospective follow-up study of 244 IgAN patients for a median of 81.9 months. Serum MMP-7 was detected at the time of diagnosis, and renal progression was assessed by Cox proportional hazards method. Results: Compared with healthy populations, the serum levels of MMP-7 were significantly elevated in IgAN patients. Besides, serum MMP-7 levels were well correlated with renal scarring lesions characterized by glomerular sclerosis and interstitial fibrosis. Follow-up analyses revealed that increased serum MMP-7 levels were linked with a greater risk of poor renal outcome with a hazard ratio of 1.898 per doubling MMP-7 concentration. By contrast with the first quartile, the risk of deterioration in renal function elevated such that the hazard ratio for the second quartile was 1.805, 3.383 for the third, and 5.173 for the fourth quartile of the MMP-7 level. Conclusions: This study showed that the higher serum MMP-7 levels were independently associated with renal fibrosis and poor prognosis in IgAN.
“…This model has proven to be useful in identifying key stress-induced microRNAs, such as miR-21 and miR-214 (Denby et al, 2011), which are upregulated during renal injury. These microRNAs have since been found to be differentially expressed in human biopsies of individuals with IgA nephropathy, and their upregulation correlates linearly with renal fibrosis (Hennino et al, 2016), demonstrating the translational relevance of this model.…”
Section: Models Of Acute and Chronic Kidney Diseasementioning
The rat has classically been the species of choice for pharmacological studies and disease modeling, providing a source of high-quality physiological data on cardiovascular and renal pathophysiology over many decades. Recent developments in genome engineering now allow us to capitalize on the wealth of knowledge acquired over the last century. Here, we review rat models of hypertension, diabetic nephropathy, and acute and chronic kidney disease. These models have made important contributions to our understanding of renal diseases and have revealed key genes, such as Ace and P2rx7, involved in renal pathogenic processes. By targeting these genes of interest, researchers are gaining a better understanding of the etiology of renal pathologies, with the promised potential of slowing disease progression or even reversing the damage caused. Some, but not all, of these target genes have proved to be of clinical relevance. However, it is now possible to generate more sophisticated and appropriate disease models in the rat, which can recapitulate key aspects of human renal pathology. These advances will ultimately be used to identify new treatments and therapeutic targets of much greater clinical relevance.
“…Later, our lab was able to effectively differentiate AKI patients from healthy patients by measuring miR-21 combined with miR-200c, miR-423 and miR-4640 in urine[114]. Since then, miR-21 has been found to be a reliable biomarker of drug-induced kidney injury[110] and fibrosis[115], and was associated with kidney injury from multiple chronic diseases including type 2 diabetes and IgA nephropathy[116, 117]. …”
Section: Mirnas In Kidney Injury and Repairmentioning
Organ damage and resulting pathologies often involve multiple deregulated pathways. MicroRNAs (miRNAs) are short, non-coding RNAs that regulate a multitude of genes at the post-transcriptional level. Since their discovery over two decades ago, miRNAs have been established as key players in the molecular mechanisms of mammalian biology including the maintenance of normal homeostasis and the regulation of disease pathogenesis. In recent years, there has been substantial progress in innovative techniques to measure miRNAs along with advances in targeted delivery of agents modulating their expression. This has expanded the scope of miRNAs from being important mediators of cell signaling to becoming viable quantitative biomarkers and therapeutic targets. Currently, miRNA therapeutics are in clinical trials for multiple disease areas and vast numbers of patents have been filed for miRNAs involved in various pathological states. In this review, we summarize miRNAs involved in organ injury and repair, specifically with regards to organs that are the most susceptible to injury: the liver, heart and kidney. In addition, we review the current state of knowledge on miRNA biology, miRNA biomarkers and nucleotide-based therapeutics designed to target miRNAs to prevent organ injury and promote repair.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.